Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose erythromycin in children with bronchiectasis
NCT03966066Unknown
- Sponsor
- Beijing Children's Hospital
- Start
- Aug 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
01
Overview
Open-label trial of erythromycin in bronchiectasis, sponsored by Beijing Children's Hospital. Primary endpoint: Change from baseline in lung function on the spirometry at 18 months. Status: unknown.
02
Drugs
erythromycin
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT03966066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03966066.